News

GK Energy Lists At ₹171/Sh Vs Issue Price Of ₹153/Sh On NSE

Railtel has received a Letter of Award (LoA) for a project valued at ₹970 crore from the Bihar Education Project Council.

Carysil, a manufacturer and exporter of home furnishing products including kitchen sinks and appliances, is in focus on Friday, September 26, following recent US tariff-related developments.

Read Full Article

Slight recovery in the market; Nifty above 24,800, rebounds over 50 points from day’s low

Habil Khorakiwala, Founder & Chairman of Wockhardt Group, highlights that 40% of US generics are made in India, warning that regulations on generics could severely affect US drug prices.

He notes that Trump’s 100% tariff on branded drugs won’t impact the company’s plans to launch the antibiotic Zaynich in the US.

Sun Pharma

The shares of Caplin Point Labs declined along with other pharma stocks.

Sanjay Parekh of Sohum Asset Managers says markets remain jittery due to ad hoc tariffs and H-1B visa uncertainty, making the near-term outlook challenging.

He remains underweight on IT but holds Infosys, and is overweight on telecom, increasing exposure to Bharti Airtel as a structural play with ARPU growth potential.

The shares of Natco Pharma have declined over 3%.

These are the top Nifty contributors as the index falls over 100 points

Waaree Energies fell nearly 5% following reports that the company is under a US investigation for allegedly evading solar tariff duties.

The shares of Wockhardt decline after Donald Trump’s pharma tariff

Markets continued their decline, with the Nifty slipping below 24,800. Leading the losses were Sun Pharma, Cipla, Asian Paints, Tech Mahindra, and Wipro.

Tata Motors rose in early trading after JLR informed CNBC-TV18 that parts of its digital infrastructure are now operational.

IT stocks fell after Accenture lowered its FY26 constant-currency revenue growth forecast to 2–5%, down from 7% in FY25, with Infosys dropping nearly 2%.

A block deal saw 90 lakh shares of VIP Industries change hands.

Balaji Subramanian, Vice President, IIFL Capital Services On CNBC-TV18

Hindustan Aeronautics’ DK Sunil said the company will deliver one Tejas Mark-1A this month and a total of three jets by the end of October.

HAL has invested nearly ₹2,000 crore to set up three production lines, and with the private sector adding a fourth line, capacity could reach 30 jets by 2027.

Pharma stocks lower on US Pharma tariff impact, Sun Pharma down over 4%

Titan equity of 0.70% amounting to ₹2050 crore, has changed hands in a large trade.

SEBI has prohibited Seacoast Shipping Services (SSSL) and its promoters from participating in securities markets for five years and ordered the recovery of nearly ₹48 crore, after determining that the company misrepresented financial statements, diverted funds, and misled investors.

Read Full Article

Market opens with minor cuts, pharma stocks under pressure on Trump

Tariffs, Nifty above 24,800

Here are a couple of stock recommendations by Mitessh Thakkar of Bonanza Portfolio

Bino Pathiparampil, Head of Research at Elara Securities

US Tariffs and Pharma

Here are a couple of stock recommendations by Shrikant Chouhan, Kotak Securities

Paras Defence & Space Technologies has secured an order valued at $3.8 million.

Siddhartha Khemka, Head-Research, Wealth Management at Motilal Oswal Financial Services, on Tata Motors: “We have been a bit underweight quite some time. Since the last two quarters, we have downgraded the stock to neutral. And what we see is that JLR continue to face several headwinds, tariff wars, US depreciation versus some of the other currencies, and uncertainty over the EV transition. I think all those things continue. On top of it, the strong competition from some of these Chinese players in other regions so we believe that near-term earnings could remain under pressure. We have cut our FY26 estimates in the last two quarters. And we believe that given the multiple headwinds, we continue to remain underweight on Tata Motors, best avoided in the current environment.”

Rupee opens at 88.69/$ vs Thursday’s close of 88.67/$

L&T Technology has partnered with Siemens to drive AI-based transformation in process engineering and smart manufacturing.

Shares of Sun Pharmaceutical Industries, India’s largest drug maker, will be under the spotlight on Friday, September 26, following US President Donald Trump’s announcement of a 100% tariff on branded and patented drugs imported into the US, effective October 1.

Read Full ArticleNewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.